2022. Study of Lopinavir/Ritonavir in Severe COVID-19 Patients with Comorbid Hypertension and Diabetes Mellitus. Indian Journal of Forensic Medicine & Toxicology. 16, 4 (Oct. 2022), 174–181. DOI:https://doi.org/10.37506/ijfmt.v16i4.18570.